Plasma Derived Therapies Market Insights Across Haemophilia and Primary Immunodeficiency Treatments

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plasma Derived Therapies Market Size, Share & Trends Analysis Report By Product Type (Immunoglobulin, Coagulation Factors, Albumin), Application Type (Haemophilia, Primary Immunodeficiency Disease, Idiopathic Thrombocytopenic Purpura), Region, Market Outlook And Industry Analysis 2035"

Plasma Derived Therapies Market Size is valued at USD 22.36 Bn in 2025 and is predicted to reach USD 46.62 Bn by the year 2035 at 8.2% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1936

Plasma-derived therapies play a critical role in the management of numerous medical conditions, including immune deficiencies, bleeding disorders, and various genetic diseases. These therapies are manufactured through plasma fractionation, a process that isolates and purifies vital proteins and antibodies from human plasma. The global market for plasma-derived therapeutics is projected to experience significant growth, driven by the increasing prevalence of chronic blood disorders, technological advancements in plasma collection and fractionation, and rising demand for safe, effective, and minimally invasive treatment options.

Market growth is further supported by demographic factors such as an aging population and the rising incidence of chronic illnesses. Plasma-derived products-including immunoglobulins, clotting factors, and albumin-remain essential for the treatment of conditions such as primary immunodeficiencies, hemophilia, and liver-related disorders. Additionally, the growing prevalence of rare diseases is fostering innovation and investment within the sector.

Medical conditions such as primary immunodeficiency, von Willebrand disease, and idiopathic thrombocytopenic purpura underscore the critical need for advanced plasma-based therapies. The increasing global demand for effective treatments for rare and complex conditions, many of which lack alternative therapeutic options, highlights the strategic significance of continued development and investment in plasma-derived therapeutics.

List of Prominent Players in the Plasma Derived Therapies Market:
• CSL Behring
• Takeda Pharmaceutical Company Limited
• Biotest AG
• Octapharma
• BPL
• ADMA Biologics
• Grifols
• Kedrion
• Kamada Pharmaceuticals
• SK Plasma
• Pfizer

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The plasma-derived therapeutics market is experiencing significant growth, primarily driven by the increasing prevalence of chronic and rare diseases. In response, governments and healthcare organizations have implemented a variety of initiatives aimed at strengthening healthcare infrastructure, thereby enhancing patient access to advanced therapies and improving overall quality of care.

These initiatives frequently include insurance coverage provisions, which improve treatment affordability and support wider adoption of plasma-derived therapies. Leading market participants are capitalizing on this favorable environment by expanding their product portfolios through accelerated research and development, facilitating the introduction of innovative plasma-based treatments and promoting global market penetration.

Challenges:
Despite promising growth prospects, the plasma-derived therapeutics sector faces operational challenges, particularly those underscored by the COVID-19 pandemic. The global health crisis disrupted healthcare operations, while simultaneously highlighting unique applications for plasma therapies. For example, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for COVID-19 convalescent plasma in August 2020, allowing its therapeutic use in hospitalized patients. Furthermore, institutions such as Houston Methodist Hospital developed plasma fractionation protocols to support patient recovery, demonstrating the potential of plasma-based interventions during emergent healthcare crises.

Regional Trends:
North America is anticipated to maintain a leading position in the global plasma-derived therapeutics market, supported by a high prevalence of chronic diseases and a well-established healthcare infrastructure. Sustained investment in research and development, combined with technological innovations and favorable regulatory frameworks, is enabling the rapid introduction and commercialization of novel plasma therapies.

The region's leadership is further reinforced by the presence of major industry players, strategic collaborations, and competitive dynamics. Additionally, supportive reimbursement policies and rising healthcare expenditures are expected to continue driving market growth, consolidating North America's dominance in the global plasma-derived therapeutics sector.

Recent Developments:
• In January 2022, The European Union (EU) announced an expansion of the indication for the subcutaneously administered human immunoglobulin cutaquig, according to Octapharma AG. Patients with acquired immune weaknesses would have more diverse treatment options thanks to the extension.
• In January 2022, The existing shareholders of Kedrion S.p.A., the Marucci family and FSI, and Permira formed a partnership to acquire and combine Kedrion with Bio Products Laboratory (BPL). The collaboration of the two businesses would become a dominant global force for drugs made from human plasma that are used to treat serious and uncommon illnesses.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1936

Segmentation of Plasma Derived Therapies Market-
By Product Type-
• Immunoglobulin
• Coagulation factors
• Albumin
• Others
By Application Type-
• Haemophilia
• Primary Immunodeficiency Disease
• Idiopathic Thrombocytopenic Purpura
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/plasma-derived-therapies-market/1936

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.